Catheters, Indwelling Clinical Trial
Official title:
A Phase 2, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Alfimeprase for Restoring Function in Occluded Central Venous Catheters
NCT number | NCT00073515 |
Other study ID # | HA003 |
Secondary ID | NuCath-1 |
Status | Completed |
Phase | Phase 2 |
First received | November 21, 2003 |
Last updated | February 2, 2010 |
Verified date | June 2005 |
Source | ARCA Biopharma, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
This trial is for patients with a central venous catheter (a vascular access device) that is not functioning properly (unable to withdraw blood). The trial compares a new blood clot dissolving agent (alfimeprase) against the currently used treatment.
Status | Completed |
Enrollment | 115 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Subjects must: - have a dysfunctional Central Venous Access Device (CVAD) defined as unable to withdraw 3 mL blood - have had the device in place for > 48 hours - be clinically stable - be 18 or older - give informed consent |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Cleveland Clinic Foundation | Cleveland | Ohio |
Lead Sponsor | Collaborator |
---|---|
ARCA Biopharma, Inc. |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00785252 -
EZIO Compared to Central Venous Lines for Emergency Vascular Access
|
N/A | |
Completed |
NCT03351725 -
Peripheral Venous Catheter Colonization Study
|
||
Completed |
NCT00272623 -
Seldinger Technique Versus Venous Cut-Down for Placement of Totally Implantable Venous Access Ports
|
N/A | |
Completed |
NCT00001518 -
A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters
|
N/A |